Product Information

ADDERALL XR 5 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $6.8140 per EA under NDC 54092038101. Its NADAC has been published 657 times since Nov 28, 2013.

DEA Schedule CII

Strength

1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1

NDC

54092038101

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021303

On Market Since

5/22/2002

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for ADDERALL XR 5 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$6.8140 per EA
All-time high$6.9795 (Mar 16, 2016)
All-time low$6.8077 (Mar 18, 2026)
52-week high$6.8193
52-week low$6.8077
Median price$6.8383
Average price$6.8539
Largest weekly change-1.8% (Mar 23, 2016)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.0%

3M

+0.1%

6M

+0.1%

1Y

-0.1%

3Y

-0.3%

5Y

+0.1%

All

-1.1%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 93%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of ADDERALL XR 5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ADDERALL XR 5 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $6.8140 per EA (NDC 54092038101), effective Jun 24, 2026.

How has the price of ADDERALL XR 5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ADDERALL XR 5 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ADDERALL XR 5 MG CAPSULE?

Since Nov 28, 2013, the NADAC for ADDERALL XR 5 MG CAPSULE has ranged from a low of $6.8077 (Mar 18, 2026) to a high of $6.9795 (Mar 16, 2016), with a median of $6.8383 per EA.

Are there cheaper alternatives to ADDERALL XR 5 MG CAPSULE?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 5 MG CAP, is $0.4661 per EA — about 93% below ADDERALL XR 5 MG CAPSULE.

Who manufactures ADDERALL XR 5 MG CAPSULE?

ADDERALL XR 5 MG CAPSULE (NDC 54092038101) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.